Patrick F. Smith, PRESIDENT, INTEGRATED DRUG Development at Certara, Inc. (CERT), sold 2,387 shares at $13.48 ($32K) on 2022-11-09, disclosed to the SEC on 2022-11-14.
Scheduled sale ($32k) by PRESIDENT, INTEGRATED DRUG Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CERT | SELL | 2024-02-21 | $90K | — | Filing → |
| CERT | SELL | 2023-06-06 | $823K | — | Filing → |
| CERT | SELL | 2022-08-18 | $177K | — | Filing → |